Profil
Myoung-Ok Kwon is the founder of Julier Partners GmbH, founded in 2013.
Currently, Dr. Kwon is a Director at Medimaps Group SA since 2022.
Dr. Kwon's former positions include Director at ImVision Therapeutics, Inc. from 2007 to 2012, Director at TRACON Pharmaceuticals, Inc. from 2011 to 2012, Director-Executive Board at ImVisioN Therapeutics AG, Asset Manager at PMG Investment Solutions AG from 2018 to 2021, and Managing Partner at Nextech Invest AG from 2007 to 2013.
Dr. Kwon's education includes a doctorate from the University of Basel and a doctorate from the Friedrich Miescher Institute.
Dr. Kwon was also an Independent Director at NLS Pharmaceutics Ltd. from 2021 to 2023.
Postes actifs de Myoung-Ok Kwon
| Sociétés | Poste | Début |
|---|---|---|
Medimaps Group SA
Medimaps Group SA Packaged SoftwareTechnology Services Develops AI driven bone microarchitecture imaging solutions for healthcare professionals | Directeur/Membre du Conseil | 28/11/2022 |
Swisscom Ventures AG
Swisscom Ventures AG Investment ManagersFinance Swisscom Ventures invests in companies located in Switzerland, the United States, Europe and Israel. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital requirements with an investment size of USD 2 - 10 million. The firm acts as lead & co-lead investor, makes co-investments, follow-on investments and also takes a seat on the board of directors. | Private Equity Investor | 01/06/2021 |
Anciens postes connus de Myoung-Ok Kwon
| Sociétés | Poste | Fin |
|---|---|---|
| NLS PHARPAR | Directeur/Membre du Conseil | 22/05/2023 |
PMG Investment Solutions AG
PMG Investment Solutions AG Investment ManagersFinance Provides investment advice | Gestionnaire de Portefeuille-Actions | 01/01/2021 |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Corporate Officer/Principal | 13/02/2014 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Directeur en chef des Investissements | 13/09/2013 |
| TRACON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2012 |
Formation de Myoung-Ok Kwon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Health Technology |
TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel targeted therapeutics for cancer treatment | Health Technology |
PMG Investment Solutions AG
PMG Investment Solutions AG Investment ManagersFinance Provides investment advice | Finance |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Finance |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Commercial Services |
Swisscom Ventures AG
Swisscom Ventures AG Investment ManagersFinance Swisscom Ventures invests in companies located in Switzerland, the United States, Europe and Israel. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital requirements with an investment size of USD 2 - 10 million. The firm acts as lead & co-lead investor, makes co-investments, follow-on investments and also takes a seat on the board of directors. | Finance |
Medimaps Group SA
Medimaps Group SA Packaged SoftwareTechnology Services Develops AI driven bone microarchitecture imaging solutions for healthcare professionals | Technology Services |
NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mental and neurobehavioral disorders | Health Technology |
Julier Partners GmbH |
















